Zobrazeno 1 - 10
of 770
pro vyhledávání: '"Chang Hwan, Choi"'
Autor:
Jeongkuk Seo, Chang Hwan Choi
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 5, Pp 697-699 (2024)
Externí odkaz:
https://doaj.org/article/54b235a502fb4fbda0fd8cba5989e5e9
Autor:
Han Na Oh, Seung Yong Shin, Jong-Hwa Kim, Jihye Baek, Hyo Jong Kim, Kang-Moon Lee, Soo Jung Park, Seok-Young Kim, Hyung-Kyoon Choi, Wonyong Kim, Woo Jun Sul, Chang Hwan Choi
Publikováno v:
Gut Pathogens, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background While significant research exists on gut microbiota changes after anti-tumor necrosis factor-alpha (anti TNF-α) therapy for ulcerative colitis, little is known about the longitudinal changes related to the effects of anti TNF-α.
Externí odkaz:
https://doaj.org/article/02afaa2d9d2c41fe86d2eafdf08aa8dc
Autor:
Hyuk Yoon, Byong Duk Ye, Sang-Bum Kang, Kang-Moon Lee, Chang Hwan Choi, Joo-young Jo, Juwon Woo, Jae Hee Cheon
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We aimed to identify the safety and effectiveness of tofacitinib in patients with UC in routine clinical settings in Korea. Methods This o
Externí odkaz:
https://doaj.org/article/19716eccc3444a97adb85097b1a70de5
Autor:
Seung Yong Shin, Hee Sung Kim, Kisung Kim, Chang Won Choi, Jung Min Moon, Jeong Wook Kim, Hyun Jin Joo, Jeongkuk Seo, Muhyeon Sung, Chang Hwan Choi
Publikováno v:
The Korean Journal of Internal Medicine, Vol 39, Iss 1, Pp 68-76 (2024)
Background/Aims We aimed to evaluate the histologic features predictive of prognosis and correlate them with endoscopic findings in patients with ulcerative colitis (UC) having complete or partial mucosal healing (MH). Methods We prospectively collec
Externí odkaz:
https://doaj.org/article/0e3d180d175649aeaeb5cac0b2fd8d42
Publikováno v:
Applied Sciences, Vol 14, Iss 12, p 5295 (2024)
Critical facilities are generally located in areas with restricted or controlled access, making it difficult for experts to monitor the structural health of enclosed infrastructures. Hence, a case study was conducted in South Korea to evaluate the ap
Externí odkaz:
https://doaj.org/article/fd44b2a967d845b3b0b2e95eecbc3beb
Autor:
Su Bum Park, Kyeong Ok Kim, Hong Sub Lee, Chang Hwan Choi, Shu Chen Wei, Min Hu Chen, Katsuyoshi Matsuoka
Publikováno v:
Intestinal Research, Vol 21, Iss 3, Pp 363-374 (2023)
Background/Aims Long-term immunosuppressive therapies used to treat inflammatory bowel disease (IBD) are associated with an increased risk of infections, many of which can be prevented by vaccination. We assessed physicians’ current approaches and
Externí odkaz:
https://doaj.org/article/2c0113577ea84c2aa7d51c708a82b912
Autor:
Soo-Young Na, Chang Hwan Choi, Eun Mi Song, Ki Bae Bang, Sang Hyoung Park, Eun Soo Kim, Jae Jun Park, Bora Keum, Chang Kyun Lee, Bo-In Lee, Seung-Bum Ryoo, Seong-Joon Koh, Miyoung Choi, Joo Sung Kim, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
Publikováno v:
Intestinal Research, Vol 21, Iss 1, Pp 61-87 (2023)
Ulcerative colitis (UC), a relapsing-remitting chronic inflammatory bowel disease (IBD), has a variable natural course but potentially severe disease course. Since the development of anti-tumor necrosis factor (TNF) agents has changed the natural dis
Externí odkaz:
https://doaj.org/article/85beb24b08fd49f5bad4ed24b2dd9990
Autor:
Seong-Joon Koh, Sung Noh Hong, Soo-Kyung Park, Byong Duk Ye, Kyeong Ok Kim, Jeong Eun Shin, Yong Sik Yoon, Hong Sub Lee, Sung Hoon Jung, Miyoung Choi, Soo-Young Na, Chang Hwan Choi, Joo Sung Kim
Publikováno v:
Intestinal Research, Vol 21, Iss 1, Pp 43-60 (2023)
Crohn’s disease (CD) is a relapsing and progressive condition characterized by diarrhea, abdominal pain, weight loss, and hematochezia that results in serious complications such as perforations, fistulas, and abscesses. Various medications, interve
Externí odkaz:
https://doaj.org/article/ca6d65dddc9140098a8f96451884b266
Autor:
Kyunghwan Oh, Hee Seung Hong, Nam Seok Ham, Jungbok Lee, Sang Hyoung Park, Suk-Kyun Yang, Hyuk Yoon, You Sun Kim, Chang Hwan Choi, Byong Duk Ye, on behalf of the Korean Association for the Study of Intestinal Diseases
Publikováno v:
Intestinal Research, Vol 21, Iss 1, Pp 137-147 (2023)
Background/Aims We investigated the real-world effectiveness and safety of ustekinumab (UST) as induction treatment for Koreans with Crohn’s disease (CD). Methods CD patients who started UST were prospectively enrolled from 4 hospitals in Korea. Al
Externí odkaz:
https://doaj.org/article/66db5b79dca14835bb286707ac079df0
Autor:
Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi, on behalf of the IBD Research Group of the Korean Association for the Study of Intestinal Diseases
Publikováno v:
Intestinal Research, Vol 21, Iss 1, Pp 148-160 (2023)
Background/Aims The fecal microbiota of Korean patients with inflammatory bowel disease (IBD) was investigated with respect to disease phenotypes and taxonomic biomarkers for diagnosis and prognosis of IBD. Methods Fecal samples from 70 ulcerative co
Externí odkaz:
https://doaj.org/article/9a10d3bc5a664161af4d4af33b0d53e1